Kenmerk
Dizziness
Klinische naam: Vertigo
An abnormal sensation of spinning while the body is actually stationary.
Samenvatting
- Ook bekend als
- Dizzy spell
- Lichaamssysteem
- Abnormality of the ear
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Dizziness, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen140 genen gekoppeld aan Dizziness
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Dizziness voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ATP6V1B1ATPase H+ transporting V1 subunit B1 | Altijd | In 1 aandoening |
| EMDemerin | Altijd | In 1 aandoening |
| FDXRferredoxin reductase | Altijd | In 1 aandoening |
| GCGRglucagon receptor | Altijd | In 1 aandoening |
| LAMB1laminin subunit beta 1 | Altijd | In 1 aandoening |
| MAU2MAU2 sister chromatid cohesion factor | Altijd | In 1 aandoening |
| NOTCH3notch receptor 3 | Altijd | In 1 aandoening |
| RFC4replication factor C subunit 4 | Altijd | In 1 aandoening |
| RRP12ribosomal RNA processing 12 homolog | Altijd | In 2 aandoeningen |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Altijd | In 2 aandoeningen |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Altijd | In 1 aandoening |
| ADA2adenosine deaminase 2 | Heel vaak (80–99%) | In 1 aandoening |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Heel vaak (80–99%) | In 6 aandoeningen |
| EPORerythropoietin receptor | Heel vaak (80–99%) | In 2 aandoeningen |
| JAK2Janus kinase 2 | Heel vaak (80–99%) | In 4 aandoeningen |
| JUPjunction plakoglobin | Heel vaak (80–99%) | In 1 aandoening |
| NAGAalpha-N-acetylgalactosaminidase | Heel vaak (80–99%) | In 3 aandoeningen |
| SLC1A3solute carrier family 1 member 3 | Heel vaak (80–99%) | In 2 aandoeningen |
| ABCC9ATP binding cassette subfamily C member 9 | Vaak (30–79%) | In 1 aandoening |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Vaak (30–79%) | In 2 aandoeningen |
| BCORBCL6 corepressor | Vaak (30–79%) | In 1 aandoening |
| CACNB4calcium voltage-gated channel auxiliary subunit beta 4 | Vaak (30–79%) | In 2 aandoeningen |
| CALRcalreticulin | Vaak (30–79%) | In 1 aandoening |
| CCND1cyclin D1 | Vaak (30–79%) | In 2 aandoeningen |
| CMPK2cytidine/uridine monophosphate kinase 2 | Vaak (30–79%) | In 1 aandoening |
| DKK1dickkopf Wnt signaling pathway inhibitor 1 | Vaak (30–79%) | In 1 aandoening |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Vaak (30–79%) | In 1 aandoening |
| GATA2GATA binding protein 2 | Vaak (30–79%) | In 1 aandoening |
| GATA4GATA binding protein 4 | Vaak (30–79%) | In 1 aandoening |
| GATA5GATA binding protein 5 | Vaak (30–79%) | In 1 aandoening |
| GATA6GATA binding protein 6 | Vaak (30–79%) | In 1 aandoening |
| GJA5gap junction protein alpha 5 | Vaak (30–79%) | In 1 aandoening |
| GYG1glycogenin 1 | Vaak (30–79%) | In 1 aandoening |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Vaak (30–79%) | In 1 aandoening |
| JAM2junctional adhesion molecule 2 | Vaak (30–79%) | In 1 aandoening |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Vaak (30–79%) | In 2 aandoeningen |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Vaak (30–79%) | In 1 aandoening |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Vaak (30–79%) | In 1 aandoening |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Vaak (30–79%) | In 1 aandoening |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Vaak (30–79%) | In 1 aandoening |
Toon nog 100 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Vaak (30–79%) | In 1 aandoening |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Vaak (30–79%) | In 1 aandoening |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Vaak (30–79%) | In 1 aandoening |
| LRP4LDL receptor related protein 4 | Vaak (30–79%) | In 1 aandoening |
| MPLMPL proto-oncogene, thrombopoietin receptor | Vaak (30–79%) | In 2 aandoeningen |
| MYD88MYD88 innate immune signal transduction adaptor | Vaak (30–79%) | In 1 aandoening |
| MYL4myosin light chain 4 | Vaak (30–79%) | In 1 aandoening |
| MYORGmyogenesis regulating glycosidase | Vaak (30–79%) | In 1 aandoening |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| NABP1nucleic acid binding protein 1 | Vaak (30–79%) | In 1 aandoening |
| NKX2-5NK2 homeobox 5 | Vaak (30–79%) | In 2 aandoeningen |
| NKX2-6NK2 homeobox 6 | Vaak (30–79%) | In 1 aandoening |
| NPM1nucleophosmin 1 | Vaak (30–79%) | In 1 aandoening |
| NPPAnatriuretic peptide A | Vaak (30–79%) | In 2 aandoeningen |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Vaak (30–79%) | In 1 aandoening |
| NUMA1nuclear mitotic apparatus protein 1 | Vaak (30–79%) | In 1 aandoening |
| NUP155nucleoporin 155 | Vaak (30–79%) | In 1 aandoening |
| PDGFBplatelet derived growth factor subunit B | Vaak (30–79%) | In 2 aandoeningen |
| PDGFRBplatelet derived growth factor receptor beta | Vaak (30–79%) | In 1 aandoening |
| PITX2paired like homeodomain 2 | Vaak (30–79%) | In 1 aandoening |
| PMLPML nuclear body scaffold | Vaak (30–79%) | In 1 aandoening |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Vaak (30–79%) | In 1 aandoening |
| PRRT2proline rich transmembrane protein 2 | Vaak (30–79%) | In 1 aandoening |
| RARAretinoic acid receptor alpha | Vaak (30–79%) | In 1 aandoening |
| RYR1ryanodine receptor 1 | Vaak (30–79%) | In 1 aandoening |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Vaak (30–79%) | In 2 aandoeningen |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Vaak (30–79%) | In 2 aandoeningen |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Vaak (30–79%) | In 1 aandoening |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Vaak (30–79%) | In 1 aandoening |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Vaak (30–79%) | In 1 aandoening |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Vaak (30–79%) | In 3 aandoeningen |
| SH2B3SH2B adaptor protein 3 | Vaak (30–79%) | In 2 aandoeningen |
| SLC20A2solute carrier family 20 member 2 | Vaak (30–79%) | In 1 aandoening |
| SRPK3SRSF protein kinase 3 | Vaak (30–79%) | In 1 aandoening |
| STAT3signal transducer and activator of transcription 3 | Vaak (30–79%) | In 1 aandoening |
| STAT5Bsignal transducer and activator of transcription 5B | Vaak (30–79%) | In 1 aandoening |
| SUFUSUFU negative regulator of hedgehog signaling | Vaak (30–79%) | In 1 aandoening |
| TBL1XR1TBL1X/Y related 1 | Vaak (30–79%) | In 1 aandoening |
| TET2tet methylcytosine dioxygenase 2 | Vaak (30–79%) | In 1 aandoening |
| TP53tumor protein p53 | Vaak (30–79%) | In 1 aandoening |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Vaak (30–79%) | In 1 aandoening |
| TTNtitin | Vaak (30–79%) | In 1 aandoening |
| VHLvon Hippel-Lindau tumor suppressor | Vaak (30–79%) | In 2 aandoeningen |
| VSX1visual system homeobox 1 | Vaak (30–79%) | In 1 aandoening |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Vaak (30–79%) | In 1 aandoening |
| ZBTB16zinc finger and BTB domain containing 16 | Vaak (30–79%) | In 1 aandoening |
| AIPAHR interacting HSP90 co-chaperone | Soms (5–29%) | In 1 aandoening |
| C4Acomplement C4A (Chido/Rodgers blood group) | Soms (5–29%) | In 1 aandoening |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Soms (5–29%) | In 1 aandoening |
| CCR1C-C motif chemokine receptor 1 | Soms (5–29%) | In 1 aandoening |
| CDH23cadherin related 23 | Soms (5–29%) | In 2 aandoeningen |
| CHD2chromodomain helicase DNA binding protein 2 | Soms (5–29%) | In 1 aandoening |
| CNNM2cyclin and CBS domain divalent metal cation transport mediator 2 | Soms (5–29%) | In 1 aandoening |
| CUX2cut like homeobox 2 | Soms (5–29%) | In 1 aandoening |
| DBHdopamine beta-hydroxylase | Soms (5–29%) | In 1 aandoening |
| DNM1dynamin 1 | Soms (5–29%) | In 1 aandoening |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Soms (5–29%) | In 1 aandoening |
| FASFas cell surface death receptor | Soms (5–29%) | In 2 aandoeningen |
| FGF14fibroblast growth factor 14 | Soms (5–29%) | In 1 aandoening |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Soms (5–29%) | In 1 aandoening |
| FOXI1forkhead box I1 | Soms (5–29%) | In 1 aandoening |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Soms (5–29%) | In 1 aandoening |
| GCDHglutaryl-CoA dehydrogenase | Soms (5–29%) | In 1 aandoening |
| GLAgalactosidase alpha | Soms (5–29%) | In 1 aandoening |
| HLA-Bmajor histocompatibility complex, class I, B | Soms (5–29%) | In 3 aandoeningen |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Soms (5–29%) | In 2 aandoeningen |
| IFNGR1interferon gamma receptor 1 | Soms (5–29%) | In 1 aandoening |
| IL10interleukin 10 | Soms (5–29%) | In 1 aandoening |
| IL12Ainterleukin 12A | Soms (5–29%) | In 1 aandoening |
| IL12A-AS1IL12A antisense RNA 1 | Soms (5–29%) | In 1 aandoening |
| IL12Binterleukin 12B | Soms (5–29%) | In 1 aandoening |
| IL23Rinterleukin 23 receptor | Soms (5–29%) | In 1 aandoening |
| KCNJ10potassium inwardly rectifying channel subfamily J member 10 | Soms (5–29%) | In 1 aandoening |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Soms (5–29%) | In 1 aandoening |
| KLRC4killer cell lectin like receptor C4 | Soms (5–29%) | In 1 aandoening |
| MAPK10mitogen-activated protein kinase 10 | Soms (5–29%) | In 1 aandoening |
| MED12mediator complex subunit 12 | Soms (5–29%) | In 1 aandoening |
| MEFVMEFV innate immunity regulator, pyrin | Soms (5–29%) | In 1 aandoening |
| MEN1menin 1 | Soms (5–29%) | In 1 aandoening |
| MLXMAX dimerization protein MLX | Soms (5–29%) | In 1 aandoening |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Soms (5–29%) | In 1 aandoening |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Soms (5–29%) | In 1 aandoening |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Soms (5–29%) | In 2 aandoeningen |
| SLC26A4solute carrier family 26 member 4 | Soms (5–29%) | In 1 aandoening |
| STAT4signal transducer and activator of transcription 4 | Soms (5–29%) | In 1 aandoening |
| THPOthrombopoietin | Soms (5–29%) | In 1 aandoening |
| TLR4toll like receptor 4 | Soms (5–29%) | In 1 aandoening |
| TNFRSF1ATNF receptor superfamily member 1A | Soms (5–29%) | In 1 aandoening |
| UBAC2UBA domain containing 2 | Soms (5–29%) | In 1 aandoening |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Zelden (1–4%) | In 1 aandoening |
| CLCNKBchloride voltage-gated channel Kb | Zelden (1–4%) | In 1 aandoening |
| CTNNB1catenin beta 1 | Zelden (1–4%) | In 1 aandoening |
| NOP56NOP56 ribonucleoprotein | Zelden (1–4%) | In 1 aandoening |
| SLC12A3solute carrier family 12 member 3 | Zelden (1–4%) | In 2 aandoeningen |
| CALM1calmodulin 1 | Niet vastgelegd | In 1 aandoening |
| COCHcochlin | Niet vastgelegd | In 1 aandoening |
| MVKmevalonate kinase | Niet vastgelegd | In 1 aandoening |
| MYL2myosin light chain 2 | Niet vastgelegd | In 1 aandoening |
| MYO7Amyosin VIIA | Niet vastgelegd | In 2 aandoeningen |
| TPK1thiamin pyrophosphokinase 1 | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken